Webcode 26112003
Dr. Johanna Huchting
Fraunhofer ITMP Discovery Research ScreeningPort
Johanna Huchting has a background in synthetic organic chemistry and cell-based assays for drug discovery. During her 15 years of research experience, she worked in the fields of carbohydrate and nucleotide chemistry, broad-spectrum antivirals, and innovative assay reagents. In her current position at Fraunhofer ITMP Discovery Research ScreeningPort, she contributes to drug repurposing projects in the Remedi4ALL framework and leads part of the PROXIDRUGS targeted protein degradation program.
Clarissa Junge-Gierse
Bird & Bird LLP
Senior Counsel, member of the Life Sciences and Healthcare Sector Group, specialised in pharmaceutical and medical devices law, focusing on market access, pricing and reimbursement strategies
More information please click here.
Christian Lindenthal, LL.M.
Bird & Bird LLP
Partner in the Munich team, he advises clients in the life sciences and healthcare sectors on matters at the intersection of IP, unfair competition and regulatory law; member of the Intellectual Property Practice Group as well as the Life Sciences and Healthcare Sector Group
More information please click here.
Dr. Jan van Dieck, LL.M.
Bird & Bird LLP
Partner and member of the intellectual property team based in Munich, he provides advice on technical property rights, particularly in the technical fields of biotechnology, pharmaceuticals and medical products.
More information please click here.
12/11/2026
12/11/2026
9h00 - 17h00
online
online
Event - 1,290€ plus tax
The participation fee includes documentation for download, a certificate, access to the Learning Space and technical support including PreMeeting.
Event - 1,290€ plus tax
The participation fee includes documentation for download, a certificate, access to the Learning Space and technical support including PreMeeting.
Dr. Henriette Wolf-Klein
Department Manager
+49 6221 500-680
h.wolf-klein@forum-institut.de
This online seminar equips regulatory affairs, IP, legal and market access professionals with practical strategies to navigate the complex journey from drug repurposing to European market authorisation and market access.
This seminar provides comprehensive insights into the regulatory, IP and market access challenges of bringing repurposed drugs to the European market.
Participants will gain practical insights into:
After having attended the seminar you will have practical hints on how to
of 5 stars of all ratings from 2025
of 5 stars on Trustpilot = good
Using AI for clinical data evaluation, systematic literature reviews, dossier writing, and PICO simulations - the essent...
Market Access of innovative medicines in Europe - here you will learn the key concepts from strategy to roll-out.
Biosimilar uptake in Europe, Aut idem in Germany - these are the challenges for regulatory affairs and market access
Using AI for clinical data evaluation, systematic literature reviews, dossier writing, and PICO simulations - the essent...
This online conference offers compact expert talks and diverse perspectives on global regulatory strategies, digital tra...
